GLP1R and diabetes mellitus: However, one observational study found SGLT-2i to be more effective than GLP-1 RA in improving cardiovascular outcomes of DM patients [38] while another showed the superiority of GLP-1 RA [39], and a third one reported no differences in major cardiovascular events between these two drug classes [40].